These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20153975)

  • 1. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.
    Morel V; Descamps V; François C; Fournier C; Brochot E; Capron D; Duverlie G; Castelain S
    J Clin Virol; 2010 Apr; 47(4):382-6. PubMed ID: 20153975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India.
    Verma V; Chakravarti A; Kar P
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):408-14. PubMed ID: 18455899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus recombinants are rare even among intravenous drug users.
    Viazov S; Ross SS; Kyuregyan KK; Timm J; Neumann-Haefelin C; Isaeva OV; Popova OE; Dmitriev PN; El Sharkawi F; Thimme R; Michailov MI; Roggendorf M
    J Med Virol; 2010 Feb; 82(2):232-8. PubMed ID: 20029799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.
    Du H; Qi Y; Hao F; Huang Y; Mao L; Ji S; Huang M; Qin C; Yan R; Zhu X; Zhang C
    J Clin Virol; 2012 Jul; 54(3):207-12. PubMed ID: 22595306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
    Zakalashvili M; Zarkua J; Weizenegger M; Bartel J; Raabe M; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Hedskog C; Chodavarapu K; Brainard DM; McHutchison JG; Mo H; Svarovskaia E; Gish RG; Rtskhiladze I; Metreveli D
    Liver Int; 2018 Mar; 38(3):451-457. PubMed ID: 28782185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains.
    Fan X; Lang DM; Xu Y; Lyra AC; Yusim K; Everhart JE; Korber BT; Perelson AS; Di Bisceglie AM
    Hepatology; 2003 Jul; 38(1):25-33. PubMed ID: 12829983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
    Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
    J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
    Kurbanov F; Tanaka Y; Chub E; Maruyama I; Azlarova A; Kamitsukasa H; Ohno T; Bonetto S; Moreau I; Fanning LJ; Legrand-Abravanel F; Izopet J; Naoumov N; Shimada T; Netesov S; Mizokami M
    J Infect Dis; 2008 Nov; 198(10):1448-56. PubMed ID: 18928375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.
    Rosen HR; Chou S; Sasaki AW; Gretch DR
    Am J Gastroenterol; 1999 Oct; 94(10):3015-9. PubMed ID: 10520862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
    Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes.
    Ross RS; Viazov S; Renzing-Köhler K; Roggendorf M
    J Med Virol; 2000 Feb; 60(2):122-5. PubMed ID: 10596009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
    J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus molecular epidemiology in Uzbekistan.
    Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
    J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary].
    Gervain J; Simon G; Papp I; Szabóné BK
    Orv Hetil; 2001 Jun; 142(25):1315-9. PubMed ID: 11488211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.